ARTICLE | Company News
Harvard Scientific Corp, Biosphere Technologies Inc deal
April 15, 2013 7:00 AM UTC
HVSF acquired exclusive rights to Prostaglandin E-1 Lyophilized Liposomes to treat psoriasis from its parent company, Biosphere Technologies. (HVSF to start clinical trials, B11). ...